CERo Therapeutics Warrants
CEROW
CEROW was delisted on the 30th of October, 2025.
22 hedge funds and large institutions have $38.1K invested in CERo Therapeutics Warrants in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
3,058.8% more ownership
Funds ownership: 34.91% → 3,093.71% (+3,059%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
4% less funds holding
Funds holding: 23 → 22 (-1)
49% less capital invested
Capital invested by funds: $74.5K → $38.1K (-$36.4K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$4.77K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.75K |
| 3 |
VF
Virtu Financial
New York
|
+$11 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Cantor Fitzgerald
New York
|
-$10.5K |
| 2 |
PA
Parallel Advisors
San Francisco,
California
|
-$401 |
| 3 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$5 |
CEROW Hedge Fund Activity: Q3 2025 in Review
22 of the 7,644 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q3 2025, worth a combined $38.1K — down 49% from $74.5K a quarter earlier.
Fund positioning in CEROW was balanced in Q3 2025: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was Clear Street, adding an estimated $4.77K. The largest seller was Cantor Fitzgerald, exiting entirely with an estimated $10.5K sold.
- 22 institutional investors held CERo Therapeutics Warrants (CEROW) as of Q3 2025, down from 23 in Q2 2025.
- Funds reported $38.1K of CERo Therapeutics Warrants stock for Q3 2025, down 49% quarter-over-quarter.
- 1 fund opened new CERo Therapeutics Warrants positions in Q3 2025 and 1 closed out, a net change of 0 holders.
- The largest CERo Therapeutics Warrants buyer in Q3 2025 was Clear Street, an estimated $4.77K added.
- The largest CERo Therapeutics Warrants seller in Q3 2025 was Cantor Fitzgerald, an estimated $10.5K sold.
Based on aggregated 13F filings for Q3 2025.